Inozyme Pharma ROE Ratio 2011-2026 | INZY

Annual ROE Ratio Inozyme Pharma

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-176.43	-50.66	-56.64	-51.82	-35.69	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-35.69	-176.43	-74.25

Quarterly ROE Ratio Inozyme Pharma

2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-166.13	-77.96	-88.34	-73.42	-61.63	-41.98	-54.13	-53.98	-57.14	-40.3	-51.63	-48.55	-45.74	-27.83	7.85	-16.49	-43.09	-35.67	23.63	47.26	109.42	145.09	59.3	59.3	26.49	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
145.09	-166.13	-20.23

ROE Ratio of other stocks in the Biotechnology industry

Issuer	ROE Ratio	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	-528.29	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	15.76	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	-32.54	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	51843.24	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	-85.31	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	5.18	-	-	$ 40.3 B	USA
Biophytis SA BPTS	-751.94	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	626.29	-	2.54 %	$ 160 B	France
AstraZeneca PLC AZN	21.0	-	-	$ 96.9 B	Britain
EyeGate Pharmaceuticals, Inc. EYEG	-115.61	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	-380.03	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	30.52	-	0.74 %	$ 768 M	Israel
Galera Therapeutics GRTX	3750.6	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	-55.98	-	-18.52 %	$ 27.3 M	Britain
Esperion Therapeutics ESPR	7.51	$ 3.14	0.16 %	$ 653 M	USA
Eton Pharmaceuticals ETON	-17.59	$ 35.13	1.97 %	$ 945 M	USA
Forte Biosciences FBRX	-113.75	$ 21.7	6.84 %	$ 281 M	USA
Институт стволовых клеток человека ISKJ	17.55	-	-	-	Russia
Checkmate Pharmaceuticals CMPI	-88.4	-	-	$ 231 M	USA
Celyad Oncology SA CYAD	-948.23	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	-69.02	-	-7.31 %	$ 87 M	USA
Grifols, S.A. GRFS	2.47	$ 8.14	-0.67 %	$ 5.53 B	Spain
Generation Bio Co. GBIO	-152.74	-	-	$ 344 M	USA
IMV IMV	575.45	-	-	$ 13.1 M	Canada
Akero Therapeutics AKRO	-33.6	-	-	$ 3.67 B	USA
BioNTech SE BNTX	-5.91	$ 91.21	0.94 %	$ 22 B	Germany
Autolus Therapeutics plc AUTL	-161.42	$ 1.66	2.47 %	$ 442 M	Britain
Ayala Pharmaceuticals AYLA	3458.87	-	-	$ 7.46 M	Israel
Heron Therapeutics HRTX	-139.54	$ 0.87	2.78 %	$ 145 M	USA
Cyclacel Pharmaceuticals CYCCP	43.82	-	-4.36 %	$ 27 M	USA
Compugen Ltd. CGEN	34.4	$ 2.61	-3.7 %	$ 244 M	Israel
Incyte Corporation INCY	24.9	$ 97.69	0.63 %	$ 19.1 B	USA
Anika Therapeutics ANIK	-7.58	$ 15.09	-0.33 %	$ 216 M	USA
Advaxis ADXS	196.88	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	-401.79	-	5.93 %	$ 314 M	Canada
Ionis Pharmaceuticals IONS	-46.9	$ 75.94	1.17 %	$ 12.2 B	USA
Aeglea BioTherapeutics AGLE	-21.7	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	-59.8	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	-62.37	-	-	$ 26.5 M	USA
Can-Fite BioPharma Ltd. CANF	-175.75	$ 3.4	2.41 %	$ 5.6 M	Israel
AIkido Pharma AIKI	-32.34	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	93.75	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	-169.38	-	-39.0 %	$ 4.57 M	USA
Coherus BioSciences CHRS	275.39	$ 1.6	5.61 %	$ 187 M	USA
Akouos AKUS	-37.09	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	-19.38	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	-55.11	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	-146.95	-	-	$ 28.6 M	USA
Arcutis Biotherapeutics ARQT	-8.52	$ 20.88	2.0 %	$ 2.66 B	USA
Allena Pharmaceuticals ALNA	-257.91	-	3.16 %	$ 1.9 M	USA